Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00502320 · ClinicalTrials.gov registry record · Phase 4
Ramelteon in the Treatment of Sleep and Mood in Patients With Seasonal Affective Disorder
A Phase 4 study, sponsored by Lehigh Valley Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
NCT00502320 is a Phase 4 study that has completed, run by Lehigh Valley Hospital. The registered enrollment target is 50 participants.
The verdict
NCT00502320, a Phase 4 study, has completed, sponsored by Lehigh Valley Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether treating sleep difficulties in patients with seasonal affective disorder also improves their depressive symptoms.
Interventions
- DRUG Placebo
- DRUG Ramelteon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2006-09 |
| Est. Completion | 2008-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00502320
The ClinicalTrials.gov registry entry for NCT00502320 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lehigh Valley Hospital, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00502320 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00502320 about?
NCT00502320 is a clinical study titled "Ramelteon in the Treatment of Sleep and Mood in Patients With Seasonal Affective Disorder". The purpose of this study is to determine whether treating sleep difficulties in patients with seasonal affective disorder also improves their depressive symptoms.
What is the current status of trial NCT00502320?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2006-09. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00502320?
The interventions under investigation include: Placebo (DRUG), Ramelteon (DRUG).
Who is sponsoring clinical trial NCT00502320?
This trial is sponsored by Lehigh Valley Hospital, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.